Evidence map›Paper›PMID 29331170›Full record

Trial reportInfection control and hospital epidemiology2018

Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices.

Deverick J Anderson, Lauren P Knelson, Rebekah W Moehring, Sarah S Lewis, David J Weber, Luke F Chen, Patricia F Triplett, Michael Blocker, R Marty Cooney, J Conrad Schwab and 4 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Infection control and hospital epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01579370 (A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01579370 nacompletednot on this map

A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes

TypeinterventionalSponsorDuke UniversityRan2012 to 2015Enrolled21,395ConditionsMultidrug Resistant Organisms, Healthcare Associated InfectionsArmsQuaternary ammonium, Bleach, Quaternary ammonium and UV-C light, Bleach and UV-C light
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Management ofInfection prevention in practice · 2026
    Article
  4. Environmental hygiene strategies to combat antimicrobial resistance in healthcare settings.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Review
  5. Article
  6. Is It Possible to Eradicate Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Deverick J Anderson1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
Lauren P Knelson1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
Rebekah W Moehring1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
Sarah S Lewis1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
David J Weber2Department of Hospital Epidemiology,University of North Carolina Health Care,Chapel Hill,North Carolina.
Luke F Chen1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
Patricia F Triplett2Department of Hospital Epidemiology,University of North Carolina Health Care,Chapel Hill,North Carolina.
Michael Blocker5Alamance Regional Medical Center,Burlington,North Carolina.
R Marty Cooney7Rex Healthcare,Raleigh,North Carolina.
J Conrad Schwab8Chesapeake Regional Medical Center,Chesapeake,Virginia.
Yuliya Lokhnygina9Department of Biostatistics and Bioinformatics,Duke University Medical Center,Durham,North Carolina.
William A Rutala2Department of Hospital Epidemiology,University of North Carolina Health Care,Chapel Hill,North Carolina.
Daniel J Sexton1Duke Center for Antimicrobial Stewardship and Infection Prevention,Duke University Medical Center,Durham,North Carolina.
CDC Prevention Epicenters Program

Funding

North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Defining Measures of Impact for Antimicrobial Stewardship Programs in Community HospitalsK08HS023866 · AHRQ · DUKE UNIVERSITY · PI MOEHRING, REBEKAH WHITE · 2015 to 2019
$739k
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a CommuniK23AI095357 · NIAID · DUKE UNIVERSITY · PI ANDERSON, DEVERICK JOHN · 2011 to 2015
$644k
AHRQ HHS K08 HS023866NCATS NIH HHS UL1 TR001111NIAID NIH HHS K23 AI095357
6 · The paper itself

Abstract

OBJECTIVE To summarize and discuss logistic and administrative challenges we encountered during the Benefits of Enhanced Terminal Room (BETR) Disinfection Study and lessons learned that are pertinent to future utilization of ultraviolet (UV) disinfection devices in other hospitals DESIGN Multicenter cluster randomized trial SETTING AND PARTICIPANTS Nine hospitals in the southeastern United States METHODS All participating hospitals developed systems to implement 4 different strategies for terminal room disinfection. We measured compliance with disinfection strategy, barriers to implementation, and perceptions from nurse managers and environmental services (EVS) supervisors throughout the 28-month trial. RESULTS Implementation of enhanced terminal disinfection with UV disinfection devices provides unique challenges, including time pressures from bed control personnel, efficient room identification, negative perceptions from nurse managers, and discharge volume. In the course of the BETR Disinfection Study, we utilized several strategies to overcome these barriers: (1) establishing safety as the priority; (2) improving communication between EVS, bed control, and hospital administration; (3) ensuring availability of necessary resources; and (4) tracking and providing feedback on compliance. Using these strategies, we deployed ultraviolet (UV) disinfection devices in 16,220 (88%) of 18,411 eligible rooms during our trial (median per hospital, 89%; IQR, 86%-92%). CONCLUSIONS Implementation of enhanced terminal room disinfection strategies using UV devices requires recognition and mitigation of 2 key barriers: (1) timely and accurate identification of rooms that would benefit from enhanced terminal disinfection and (2) overcoming time constraints to allow EVS cleaning staff sufficient time to properly employ enhanced terminal disinfection methods. TRIAL REGISTRATION Clinical trials identifier: NCT01579370 Infect Control Hosp Epidemiol 2018;39:157-163.

Indexed as

Attitude of Health PersonnelUltraviolet RaysCross InfectionDisinfectionGuideline AdherenceHospitalsHumansInfection ControlInterprofessional RelationsNurse AdministratorsPatients' RoomsSoutheastern United StatesSurveys and Questionnaires

Identifiers

PMID29331170
PMCPMC5935456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.